bicycle therapeutics Logo (WIPO, 26.11.2021)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke bicycle therapeutics wurde als Bildmarke am 26.11.2021 bei der Weltorganisation für geistiges Eigentum angemeldet.
Logodesign (Wiener Klassifikation)
#Buchstaben oder Ziffern, die geometrische Figuren bilden, Schrift- oder typografische Gegenstände in perspektivischer Darstellung #Briefe, die eine besondere Form des Schreibens darstellen #Farben #Zwei vorherrschende Farben
| Markenform | Bildmarke |
| Aktenzeichen | 1688031 |
| Registernummer | UK00003657018 |
| Länder | 
|
| Basismarke |
Nr. UK00003657018,
29. Oktober 2021
|
| Anmeldedatum | 26. November 2021 |
| Ablaufdatum | 26. November 2031 |
Markeninhaber
Building 900,
Babraham Research Campus,
GB
Babraham Research Campus,
GB
Markenvertreter
Lacon London,
84 Theobalds Road,
GB
Waren und Dienstleistungen
05
Pharmaceuticals; pharmaceutical preparations; pharmaceutical
products; pharmaceutical products and preparations for use
in relation to oncology; pharmaceutical products and
preparations for use in relation to ophthalmology;
pharmaceutical products and preparations for use in relation
to neurology; anti-infective pharmaceutical products and
preparations; pharmaceutical products and preparations for
the treatment and/or prevention of respiratory disease;
pharmaceutical products and preparations for the treatment
and/or prevention of cardiovascular disease; pharmaceutical
products and preparations for the treatment and/or
prevention of metabolic disease; pharmaceutical products and
preparations for the treatment and/or prevention of viral
infections; pharmaceutical products and preparations for use
in diagnostics and imaging; pharmaceutical products and
preparations for the treatment and/or prevention of renal
disease; pharmaceutical products and preparations for the
treatment and/or prevention of gastrointestinal disease;
pharmaceutical products and preparations for the treatment
and/or prevention of muscular skeletal disease
42
Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; pharmaceutical research and development services;
medical research and development services; pharmaceutical
testing and clinical trials; clinical trials; research and
development in the field of oncology; research and
development in the field of ophthalmology; research and
development in the field of neurology; research and
development in the field of anti-infective pharmaceuticals;
research and development in the field of respiratory
disease; research and development in the field of
cardiovascular disease; research and development in the
field of metabolic disease; research and development in the
field of antiviral drugs; research and development in the
field of diagnostics and imaging; research and development
in the field of renal disease; research and development in
the field of gastrointestinal disease; research and
development in the field of muscular skeletal disease;
information consultancy and advisory services relating to
the aforesaid
44
Medical services; healthcare services; pharmaceutical
services; medical consulting services; advisory services
relating to pharmaceuticals; consultancy and information
services relating to pharmaceuticals; medical services in
the field of oncology; medical services in the field of
ophthalmology; medical services in the field of neurology;
medical services in the field of anti-infectives; medical
services in connection with respiratory disease; medical
services in connection with cardiovascular disease; medical
services in connection with metabolic disease; medical
services in connection with the treatment and/or prevention
of viral infections; medical services in connection with
diagnostics and imaging; medical services in connection with
renal disease; medical services in connection with
gastrointestinal disease; medical services in connection
with muscular skeletal disease; pharmaceutical services in
the field of oncology; pharmaceutical services in the field
of ophthalmology; pharmaceutical services in the field of
neurology; pharmaceutical services in the field of
anti-infectives; pharmaceutical services in connection with
respiratory disease; pharmaceutical services in connection
with cardiovascular disease; pharmaceutical services in
connection with metabolic disease; pharmaceutical services
in connection with the treatment and/or prevention of viral
infections; pharmaceutical services in connection with
diagnostics and imaging; pharmaceutical services in
connection with renal disease; pharmaceutical services in
connection with gastrointestinal disease; pharmaceutical
services in connection with muscular skeletal disease;
information, consultancy and advisory services relating to
the aforesaid; medical testing
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 20. Juli 2023 | 2023/29 Gaz | JP | Ablehnung |
| 01. März 2023 | 2023/9 Gaz | EM | Ablehnung |
| 23. Dezember 2022 | 2022/52 Gaz | US | Ablehnung |
| 26. November 2021 | 2022/38 Gaz | GB | Eintragung |
ID: 141688031